1991
DOI: 10.1016/0014-2999(91)90132-a
|View full text |Cite
|
Sign up to set email alerts
|

Effect of nifedipine on cyclosporine A-induced nephrotoxicity, urinary endothelin excretion and renal endothelin receptor number

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

1991
1991
2000
2000

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(13 citation statements)
references
References 7 publications
0
13
0
Order By: Relevance
“…The extraction and radioimmunoassay for endothelin have been described previously (Brooks et al, 1991). The antiserum used had 100% cross-reactivity with endothelin-1, -2 and -3 and <0.001% cross-reactivity with porcine proendothelin (1-39) or human proendothelin (1-38).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The extraction and radioimmunoassay for endothelin have been described previously (Brooks et al, 1991). The antiserum used had 100% cross-reactivity with endothelin-1, -2 and -3 and <0.001% cross-reactivity with porcine proendothelin (1-39) or human proendothelin (1-38).…”
Section: Methodsmentioning
confidence: 99%
“…There is growing evidence that endothelin is involved in a variety of acute renal disorders including cyclosporine A nephrotoxicity. Thus, an endothelin antibody can attenuate cyclosporine Ainduced renal vasoconstriction (Kon et al, 1990;Perico et al, 1990) and there is increased endothelin binding (Nambi et al, 1990) and urinary excretion (Brooks et al, 1991) in rats and man (Deray et al, 1991) with cyclosporine A-induced nephrotoxicity. Since endothelin is a powerful renal vasoconstrictor and causes proliferation of mesangial cells in culture (Simonson et al, 1989;Jaffer et al, 1990), it may also be involved in chronic renal disease.…”
Section: Introductionmentioning
confidence: 99%
“…The exact role played by ET in CsA-induced vasoconstriction is uncertain. A number of investigators have demonstrated an increase in urinary ET excretion in rats after acute CsA infusion (10,11). The study of Bunchman et al ( 12) showing concentration-dependent CsA induction of ET synthesis in cultured endothelial cells would indicate that CsA may directly stimulate increased ET activity in the systemic or renal vasculature.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, investigators have focused on the possibility that endothelin may play a role in the response to radiocontrast media. Endothelin (ET), first discovered by Yanagisawa et al [5], is the most potent vasoconstrictor agent yet identified [5][6][7], Two subtypes of ET receptors (ETA and ETB) have been identified, cloned and sequenced [8,9] and there is growing evidence that ET and its receptors may play an important role in a number of renal diseases including ischemia-induced acute renal failure [10][11][12][13][14], cyclosporine A nephrotoxicity [15][16][17], and progressive glomerular disease [18][19][20], Evi dence for a role of ET in radiocontrast media-induced nephrotoxicity includes observations that radiocontrast media increases plasma and urinary endothelin [21][22][23] and an ET receptor antagonist can decrease the effect of iothalamate on renal blood flow [4], Furthermore, many radiocontrast media arc high osmolar and evidence indi cates that hyperosmolality can regulate both ET-1 produc tion and ET-1 mRNA expression in kidney cells or the inner medullary collecting duct in vitro [24][25][26]. In the present study, we have therefore studied the effect of the novel nonpeptide endothelin receptor antagonist, SB 209670, on the renal effects of Hypaque in anesthe tized dogs.…”
Section: Introductionmentioning
confidence: 99%